Bibliographic Details
| Title: |
Cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors as combination therapy with metformin in the treatment of type 2 diabetes mellitus without established cardiovascular disease in Colombia. |
| Authors: |
Lasalvia P; Department of Economic Studies, NeuroEconomix, Bogota, Colombia., Gil-Rojas Y; Department of Economic Studies, NeuroEconomix, Bogota, Colombia., García Á; Cardiology Unit, San Ignacio University Hospital. Pontificia Universidad Javeriana, Bogotá, Colombia. |
| Source: |
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2022 Sep; Vol. 22 (6), pp. 955-964. Date of Electronic Publication: 2022 Mar 08. |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8379 (Electronic) Linking ISSN: 14737167 NLM ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
